G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 2 GBX 5.26% Market Closed
Market Cap: 5.7m GBX

Wall Street
Price Targets

GENI Price Targets Summary
Genincode PLC

There are no price targets for GENI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genincode PLC Competitors:
Price Targets
CCEL
Cryo-Cell International Inc
81% Upside
OPCH
Option Care Health Inc
31% Upside
DGX
Quest Diagnostics Inc
12% Upside
FRE
Fresenius SE & Co KGaA
18% Upside
AHX
Apiam Animal Health Ltd
11% Upside
1846
Euroeyes International Eye Clinic Ltd
96% Upside
VVOS
Vivos Therapeutics Inc
37% Downside
4544
H.U. Group Holdings Inc
3% Downside

Revenue
Forecast

Revenue Estimate
Genincode PLC

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

33%
Past Growth
225%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENI's stock price target?
Not Available

GENI doesn't have any price targets made by Wall Street professionals.

What is Genincode PLC's Revenue forecast?
Projected CAGR
225%

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

Back to Top